Determine the necessary mass, volume, or concentration for preparing a solution.
This is a demo store. No orders will be fulfilled.
| SKU | Size | Availability |
Price | Qty |
|---|---|---|---|---|
|
R129954-50mg
|
50mg |
Available within 4-8 weeks(?)
Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience!
|
$31.90
|
|
|
R129954-250mg
|
250mg |
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
|
$103.90
|
|
|
R129954-1g
|
1g |
3
|
$309.90
|
|
|
R129954-5g
|
5g |
3
|
$1,030.90
|
|
|
R129954-25g
|
25g |
2
|
$3,434.90
|
|
Osteoclast-mediated bone resorption inhibitor
| Synonyms | AC-20120 | Acrel | D00942 | H11438 | Sodium trihydrogen (1-hydroxy-2-(3-pyridyl)ethylidene)diphosphonate | DRFDPXKCEWYIAW-UHFFFAOYSA-M | Risedronate (sodium) | Risedronate sodium 2.5-hydrate, European Pharmacopoeia (EP) Reference Standard | Risedronate so |
|---|---|
| Specifications & Purity | ≥98% |
| Biochemical and Physiological Mechanisms | Risedronate sodium is a pyridinyl biphosphonate which inhibits osteoclast-mediated bone resorption. Risedronate sodium is an inhibitor of FDPS.Osteoclast-mediated bone resorption inhibitor. Promotes osteoblast differentiation and reduces osteocyte apoptos |
| Storage Temp | Store at 2-8°C |
| Shipped In |
Wet ice This product requires cold chain shipping. Ground and other economy services are not available. |
| Action Type | INHIBITOR |
| Mechanism of action | Farnesyl diphosphate synthase inhibitor |
| Note | Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details. |
| Product Description |
Risedronate Sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone. |
Taxonomy Tree
| Kingdom | Organic compounds |
|---|---|
| Superclass | Organic acids and derivatives |
| Class | Organic phosphonic acids and derivatives |
| Subclass | Bisphosphonates |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Bisphosphonates |
| Alternative Parents | Pyridines and derivatives Organic phosphonic acids Heteroaromatic compounds Azacyclic compounds Organopnictogen compounds Organophosphorus compounds Organooxygen compounds Organonitrogen compounds Organic zwitterions Organic sodium salts Organic oxides Hydrocarbon derivatives |
| Molecular Framework | Aromatic heteromonocyclic compounds |
| Substituents | Bisphosphonate - Pyridine - Organophosphonic acid - Heteroaromatic compound - Organoheterocyclic compound - Organic alkali metal salt - Azacycle - Organic nitrogen compound - Organic sodium salt - Organic salt - Organic zwitterion - Organopnictogen compound - Organophosphorus compound - Organooxygen compound - Organonitrogen compound - Organic oxygen compound - Organic oxide - Hydrocarbon derivative - Aromatic heteromonocyclic compound |
| Description | This compound belongs to the class of organic compounds known as bisphosphonates. These are organic compounds containing two phosphonate groups linked together through a carbon atoms. |
| External Descriptors | Not available |
|
|
|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Pubchem Sid | 504762908 |
|---|---|
| Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/504762908 |
| IUPAC Name | sodium;hydroxy-(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphinate |
| INCHI | InChI=1S/C7H11NO7P2.Na/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6;/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15);/q;+1/p-1 |
| InChIKey | DRFDPXKCEWYIAW-UHFFFAOYSA-M |
| Smiles | C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+] |
| Isomeric SMILES | C1=CC(=CN=C1)CC(O)(P(=O)(O)O)P(=O)(O)[O-].[Na+] |
| WGK Germany | 3 |
| RTECS | SZ8567200 |
| Alternate CAS | 105462-24-6,329003-65-8 |
| PubChem CID | 4194514 |
| Molecular Weight | 305.09 |
Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
| Certificate of Analysis | Aug 22, 2024 | R129954 | |
| Certificate of Analysis | Aug 22, 2024 | R129954 | |
| Certificate of Analysis | Aug 22, 2024 | R129954 | |
| Certificate of Analysis | Dec 04, 2023 | R129954 | |
| Certificate of Analysis | Dec 04, 2023 | R129954 | |
| Certificate of Analysis | May 10, 2023 | R129954 |
| Solubility | DMSO Water 2 mg/mL Ethanol;Soluble in water, insoluble in ethanol |
|---|---|
| Sensitivity | Moisture and heat sensitive |
| Molecular Weight | 305.090 g/mol |
| XLogP3 | |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 4 |
| Exact Mass | 304.983 Da |
| Monoisotopic Mass | 304.983 Da |
| Topological Polar Surface Area | 151.000 Ų |
| Heavy Atom Count | 18 |
| Formal Charge | 0 |
| Complexity | 375.000 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| The total count of all stereochemical bonds | 0 |
| Covalently-Bonded Unit Count | 2 |